Literature DB >> 23569386

Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.

Dong Xu1, Tienan Bi, Huanrong Lan, Wenjie Yu, Wenmin Wang, Feilin Cao, Ketao Jin.   

Abstract

Syringocystadenoma papilliferum (SCAP) is an uncommon benign adnexal tumor of the skin. It is frequently seen in association with other benign adnexal lesions, such as nevus sebaceous, apocrine nevus, tubular apocrine adenoma, apocrine hidrocystoma, apocrine cystadenoma, and clear cell syringoma. The unusual reported locations of SCAP include the head and neck, the buttock, the vulva, the scrotum, the pinna, the eyelid, the outer ear canal, the forehead, the back, the scalp, the thigh, the nipple, the axilla, and the postoperative scar. The occurrence of SCAP in the right lower abdomen is distinctly uncommon. Herein, we report an unusual case of a 41-year-old man with SCAP occurring in the right lower abdomen that did not develop malignancy, despite a long disease course and an absence of medical treatment. The clinical and histopathologic features and the differential diagnosis of SCAP are also discussed.

Entities:  

Keywords:  adnexal; benign; skin tumor

Year:  2013        PMID: 23569386      PMCID: PMC3615882          DOI: 10.2147/OTT.S42732

Source DB:  PubMed          Journal:  Onco Targets Ther        ISSN: 1178-6930            Impact factor:   4.147


Introduction

Syringocystadenoma papilliferum (SCAP) is a rare, benign adnexal tumor that, in 50% of cases, is present at birth or in early childhood, while in another 15%–30% of cases, develops during puberty.1,2 Although benign, its transition to basal cell carcinoma, metastatic adenocarcinoma, and ductal carcinoma may occur.3,4 SCAP often occurs in association with other benign adnexal lesions, such as nevus sebaceous,5 apocrine nevus,6 tubular apocrine adenoma,7,8 apocrine hidrocystoma, apocrine cystadenoma,9 and clear cell syringoma.10 According to Shams et al,11 there have been 261 reported cases. Roughly 50% present at birth or in early childhood.11 Most often, SCAP is asymptomatic. It can have a variable clinical presentation, appearing as a solitary papule or a linear arrangement of several papules. With increasing size, a more prominent papillary configuration develops, and the surface can become scabbed. Macroscopically, the mature lesion consists of clusters of generally pinkish-brown nodules, 2–10 mm in diameter, with an occasional central opening. During puberty, SCAP may increase in size and develop a crusted and papillomatous texture.12 The most common location is the head and neck,13–15 and it is really rare to see SCAP located in the abdomen. We report here a fourth case of SCAP in the right lower abdomen that did not develop malignancy, despite a long disease course and an absence of medical treatment.

Case report

A 41-year-old man was referred to the Department of Surgical Oncology, Taizhou Hospital (Linhai, People’s Republic of China) in November 2012, with a giant sessile, moist, pinkish tumor located in the right lower abdomen. He reported having a small elevated nodular swelling in the right lower abdomen for the past three decades. The patient reported that during this time, the tumor had slowly, but consistently, increased in size and over the past 2 years had become more noticeable, combined with painful itching and bleeding on touching. In November 2012, the patient finally sought treatment because of local pain and bleeding from the tumor. Physical examination revealed a giant 4.0 × 2.0 cm brownish, verrucous tumor (Figure 1). The tumor surface was a moist, pinkish mass with a few hemorrhagic areas. Though the clinical suspicion was either a squamous cell or a basal cell carcinoma, the initial pathologic diagnosis of a small wedge biopsy specimen was SCAP, with no evidence of malignancy. The mass was excised along with a 3 mm margin of healthy skin. The final pathologic diagnosis of the excised specimen confirmed the initial report.
Figure 1

Clinical appearance before surgery.

Notes: The photograph shows a large, sessile, moist, pinkish mass with a few hemorrhagic areas in the right lower abdomen.

Histopathologically, the tumor was characterized by a number of cystic invaginations extending downwards from the epidermis (Figure 2A and B). Numerous papillary projections extended into the lumen of these invaginations. The papillary projections were lined with a two-layer epithelium comprising an inner cylindrical and an outer cuboidal layer. A dense dermal cellular infiltrate, consisting primarily of plasma cells and lymphocytes, was prominent in the papillary projections. The histological findings were consistent with a verrucous form of SCAP (Figure 2A and B).
Figure 2

(A) Low power view showing a double-layered epithelial lining comprised of tubular structures, with dense plasma cells and lymphocyte infiltrate in the stroma (original magnification ×100); (B) High power view showing a double layer of epithelium lining the papillary surfaces, with a columnar layer on the luminal side and a cuboidal layer on the other (original magnification ×400).

Note: Hematoxylin and eosin staining.

Discussion

SCAP is an uncommon skin adnexal tumor of sweat gland origin that usually occurs as a solitary lesion. Although most lesions are not clinically distinctive and require biopsy for diagnosis, the tumor is usually described as a skin-colored to pink, hairless, firm plaque of grouped nodules or as a solitary nodule, but verrucous, papillary, hyperkeratotic, moist, fleshy excrescences have also been described. Some tumors may show central umblication, through which small fistulae may discharge fluid. The great majority of SCAP arise on the head and neck.13 Other unusual reported locations of SCAP include the buttock,16 vulva and scrotum,17,18 pinna,19 eyelid,20–22 outer ear canal,23 postoperative scar,24 scalp,25 nipple,26 thigh,27 axilla,28 and back,29 but only three cases in the right lower abdomen were previously reported.30–32 To our knowledge, this is the fourth case reported. Most of the lesions develop and enlarge gradually, although a few can attain considerable size within a few months. Clinically, SCAP presents with a range of nonspecific lesions. Diagnosis may be confirmed by histopathology. One study reported that ultrastructurally, although there were some variations in the electron density of the cells, the constituent epithelial cells were mainly divided into three types: luminal cells, basal cells, and clear cells.33 The differential diagnosis of SCAP includes hidradenoma papilliferum, papillary eccrine adenomas, warty dyskeratoma, and inverted follicular keratosis. Clinically, SCAP presents as raised warty plaques on the head and neck, often in the setting of nevus sebaceus. Ducts invaginate from the surface into the dermis. Papillary fronds extend upward from the base, while plasma cells are common in the core of each frond.9 Hidradenoma papilliferum similarly differentiates towards the secretory portion of the sweat gland but is more common on the vulva, breast, or eyelid, and unlike SCAP, there is no epidermal connection with hidradenoma papilliferum (it “hides” in the dermis). The dermal nodule of hidradenoma papilliferum consists of ducts that are arborized in a mazelike pattern, without plasma cell cores. Papillary eccrine adenomas are composed of multiple, dermal, dilated, duct-like spaces containing papillary projections. Similar to SCAP, warty dyskeratoma and inverted follicular keratosis show an endophytic pattern. However, warty dyskeratomas are lined by elongated dermal papillae with suprabasilar acantholysis of keratinocytes, some of which are dyskeratotic, and inverted follicular keratosis resembles an expanded hair follicle, with squamous eddies (whorls of mature squamous epithelium). The histogenesis of SCAP is uncertain. Whether SCAP is derived from apocrine or eccrine glands is undetermined.11,34 Immunohistochemical studies conducted by Mazoujian and Margolis35 support an apocrine origin, whereas ultrastructural analysis favors an eccrine derivation.36 Alternatively, it has been speculated that SCAP might arise from pluripotent stem cells.33 This would support a mix of apocrine and eccrine elements. Cases of SCAP are limited. The only treatment for SCAP is excision biopsy, which also confirms the diagnosis. CO2 laser excision of SCAP of the head and neck is a clinical treatment option in anatomic areas that are unfavorable for excision and grafting.37 SCAP has also been successfully treated with Mohs micrographic surgery.38 In conclusion, SCAP is an uncommon sweat gland tumor with a widely variable clinical appearance. The peculiarity of our case lies in the rarity of SCAP and its location in the right lower abdomen. We believe that the present case is the fourth report of SCAP in the right lower abdomen. Our case represents an unusual presentation of an uncommon tumor at a rare location, with significant impairment in quality of life that improved after surgical excision.
  37 in total

1.  Syringocystadenoma papilliferum arising on the scrotum.

Authors:  Junko Goshima; Hiroyuki Hara; Tomoyoshi Okada; Hiroyuki Suzuki
Journal:  Eur J Dermatol       Date:  2003 May-Jun       Impact factor: 3.328

2.  An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.

Authors:  Wan-Lung Lin; Wen-Chi Lin; Tseng-Tong Kuo; Chien-Hsun Chen; Hong-Shang Hong
Journal:  Dermatol Surg       Date:  2007-07       Impact factor: 3.398

3.  Report of 3 histopathologically documented cases of syringocystadenoma papilliferum involving the eyelid.

Authors:  Ayman Helmi; Ahmad M Alaraj; Hind Alkatan
Journal:  Can J Ophthalmol       Date:  2011-05-27       Impact factor: 1.882

4.  Syringocystadenoma papilliferum on the male nipple.

Authors:  Masahisa Shindo; Nanako Yamada; Yuichi Yoshida; Osamu Yamamoto; Shinichi Morino
Journal:  J Dermatol       Date:  2011-02-01       Impact factor: 4.005

5.  Syringocystadenoma papilliferum: report of first case on the pinna.

Authors:  J Bakshi; P K Parida
Journal:  J Laryngol Otol       Date:  2006-11-14       Impact factor: 1.469

6.  Syringocystadenoma papilliferum associated with apocrine poroma.

Authors:  Toshihiro Suzuki; Hideyuki Ikeda; Yoichiro Hamasaki; Atsushi Hatamochi; Soji Yamazaki
Journal:  J Dermatol       Date:  2006-04       Impact factor: 4.005

7.  Syringocystadenoma papilliferum: a study of potential tumor suppressor genes.

Authors:  R Böni; H Xin; D Hohl; R Panizzon; G Burg
Journal:  Am J Dermatopathol       Date:  2001-04       Impact factor: 1.533

Review 8.  Syringocystadenoma papilliferum on the thigh: an unusual location.

Authors:  Purnima Malhotra; Avninder Singh; V Ramesh
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 Mar-Apr       Impact factor: 2.545

9.  Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.

Authors:  G Mazoujian; R Margolis
Journal:  Am J Dermatopathol       Date:  1988-02       Impact factor: 1.533

10.  Condyloma acuminatum associated with syringocystadenoma papilliferum.

Authors:  H G Skelton; K J Smith; D Young; G P Lupton
Journal:  Am J Dermatopathol       Date:  1994-12       Impact factor: 1.533

View more
  3 in total

1.  Syringocystadenoma papilliferum of the upper lip.

Authors:  Hamdan A Al-Habsi; Mustafa Al-Hinai; Ahmed Al-Waily; Salim Al-Sudairy; Vipula de Silva
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

2.  Syringocysadenoma papilliferum of the vulva: a rarity in gynaecology.

Authors:  Oleksandr Steshenko; Nirmala Chandrasekaran; Frank Lawton
Journal:  BMJ Case Rep       Date:  2014-05-28

3.  Neonatal syringocystadenoma papilliferum: A case report.

Authors:  Hong-Jing Jiang; Zhao Zhang; Li Zhang; Yun-Jing Pu; Nian Zhou; Hong Shu
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.